Skip to main content
NVAX logo
NVAX
(NASDAQ)
Novavax, Inc.
$7.83-- (--)
Loading... - Market loading

Novavax (NVAX) Stock Price & Financial Analysis

Novavax Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$7.72 - $7.91
52-Week High$11.97
52-Week Low$6.20
Open$7.83
Volume2.38M
Average Volume (3M)3.88M
Market Cap1.28B
Shares Outstanding163.28M
Price to Sales (P/S)2.14
Price to Book (P/B)-8.83
EV/EBITDA-24.88
Revenue (TTM)596.34M
Net Income (TTM)-87.83M
Free Cash Flow (TTM)-97.17M
EPS (TTM)$-0.52
Profit Margin-14.73%
Operating Margin4.31%
50-Day MA$9.20
200-Day MA$8.51
52-Week Change-0.19%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Novavax

What is the current stock price for NVAX?

As of the latest trading session, NVAX stock trades at $7.83. The 52-week range is $6.20–$11.97, with a day range of $7.72–$7.91.

What is the P/E ratio for NVAX?

The P/E ratio (Price-to-Earnings) for NVAX is shown in the Key Statistics section. This valuation metric helps compare Novavax, Inc. to industry peers.

Does NVAX pay dividends?

Novavax does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NVAX?

Based on 4 analysts, the consensus for NVAX is Sell.

What is the market cap of NVAX?

Novavax's market capitalization is $1.28B, classifying it as a small-cap company. Novavax operates in the Healthcare sector within the Biotechnology industry.